Nanomedicine for safe healing of bone trauma: Opportunities and challenges

被引:58
作者
Behzadi, Shahed [1 ,2 ]
Luther, Gaurav A. [3 ]
Harris, Mitchel B. [3 ]
Farokhzad, Omid C. [1 ,2 ,4 ]
Mahmoudi, Morteza [1 ,2 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Ctr Nanomed, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA
[4] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia
基金
美国国家卫生研究院;
关键词
Nanomedicine; Bone regeneration; Antibacterial properties; Stem cells; MESOPOROUS SILICA NANOPARTICLES; SEVERE OPEN FRACTURES; CALCIUM-PHOSPHATE; IN-VITRO; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; SILVER NANOPARTICLE; INTERNAL-FIXATION; ANTIBACTERIAL PROPERTIES; MAGNETIC NANOPARTICLES;
D O I
10.1016/j.biomaterials.2017.09.005
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Historically, high-energy extremity injuries resulting in significant soft-tissue trauma and bone loss were often deemed unsalvageable and treated with primary amputation. With improved soft-tissue coverage and nerve repair techniques, these injuries now present new challenges in limb-salvage surgery. High-energy extremity trauma is pre-disposed to delayed or unpredictable bony healing and high rates of infection, depending on the integrity of the soft-tissue envelope. Furthermore, orthopedic trauma surgeons are often faced with the challenge of stabilizing and repairing large bony defects while promoting an optimal environment to prevent infection and aid bony healing. During the last decade, nanomedicine has demonstrated substantial potential in addressing the two major issues intrinsic to orthopedic traumas (i.e., high infection risk and low bony reconstruction) through combatting bacterial infection and accelerating/increasing the effectiveness of the bone-healing process. This review presents an overview and discusses recent challenges and opportunities to address major orthopedic trauma through nanomedical approaches. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:168 / 182
页数:15
相关论文
共 170 条
[31]   Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing [J].
Cho, TJ ;
Gerstenfeld, LC ;
Einhorn, TA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (03) :513-520
[32]   Emerging role of bone morphogenetic proteins in angiogenesis [J].
David, Laurent ;
Feige, Jean-Jacques ;
Bailly, Sabine .
CYTOKINE & GROWTH FACTOR REVIEWS, 2009, 20 (03) :203-212
[33]   Aggressive treatment of 119 open fracture wounds [J].
DeLong, WG ;
Born, CT ;
Wei, SY ;
Petrik, ME ;
Ponzio, R ;
Schwab, CW .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1999, 46 (06) :1049-1054
[34]   Modelling bone tissue fracture and healing:: a review [J].
Doblaré, M ;
García, JM ;
Gómez, MJ .
ENGINEERING FRACTURE MECHANICS, 2004, 71 (13-14) :1809-1840
[35]  
Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO
[36]  
2-1
[37]  
Dubos R., 1955, Lancet, V266, pxxiv
[38]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[39]  
DUELAND R, 1982, CLIN ORTHOP RELAT R, P264
[40]   The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization [J].
Eijken, M ;
Koedam, M ;
van Driel, M ;
Buurman, CJ ;
Pols, HAP ;
van Leeuwen, JPTM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) :87-93